Player FM - Internet Radio Done Right
21 subscribers
Checked 3h ago
Adăugat four ani în urmă
Content provided by Proactive Investors. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Proactive Investors or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Player FM - Aplicație Podcast
Treceți offline cu aplicația Player FM !
Treceți offline cu aplicația Player FM !
Podcasturi care merită ascultate
SPONSORIZAT
N
Now On Netflix
1 American Primeval & Back in Action 18:21
18:21
Redare mai Târziu
Redare mai Târziu
Liste
Like
Plăcut
18:21In a difficult week for Los Angeles, we hope this episode can provide a little bit of respite. Jessica Shaw is joined by Keely Flaherty from Tudum for a deeper dive into the gripping limited series, American Primeval , starring Betty Gilpin and Taylor Kitsch. Then also talk about the delightful return of Cameron Diaz and Jamie Foxx in the new action comedy, Back in Action , directed by Seth Gordon. Follow Netflix Podcasts for more and read about all of the titles featured on today’s episode exclusively on Tudum.com .…
Just the Facts: Terra Metals expands Dante Reefs potential
Manage episode 456266564 series 2891889
Content provided by Proactive Investors. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Proactive Investors or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from Terra Metals Ltd (ASX:TM1, OTC:PNGZF). The company has provided new assay results confirming the scale and continuity of its Dante Reefs discovery in Western Australia. The project exhibits consistent Bushveld-style mineralisation of copper, gold, platinum group metals (PGMs), titanium and vanadium from surface, reinforcing its potential for a significant sulphide deposit in the low-risk West Musgrave region. Highlights from phase one diamond drilling include, 7.7 metres at 0.27% copper, 18.4% titanium and 0.68% vanadium. Phase two RC drilling highlights include 5 metres at 0.86 g/t PGE, 0.26% copper and 19.2% titanium. Pending assays from 68 additional drill holes are expected to expand the resource. The first round of infill drilling at Reef 1 has reinforced the company’s confidence in the discovery’s continuity and scale. The project is geologically analogous to South Africa's Bushveld Complex, a globally significant source of critical minerals. Terra Metals plans to continue systematic exploration while advancing metallurgical test work, with updates expected in 2025. The company remains committed to proving the full potential of the Dante Reefs discovery. #ProactiveInvestors #TerraMetals #ASX #OTC #DanteReefs, #Copper, #PGMs, #Titanium, #Vanadium, #CriticalMinerals, #BushveldStyle, #MiningExploration, #WestMusgrave, #AustralianMining, #ResourceExpansion, #MineralDiscovery, #MetallurgicalTesting, #Tier1Mining, #MiningPotential, #GoldExploration, #MiningUpdates, #SustainableMining, #Mineralisation
…
continue reading
607 episoade
Manage episode 456266564 series 2891889
Content provided by Proactive Investors. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Proactive Investors or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from Terra Metals Ltd (ASX:TM1, OTC:PNGZF). The company has provided new assay results confirming the scale and continuity of its Dante Reefs discovery in Western Australia. The project exhibits consistent Bushveld-style mineralisation of copper, gold, platinum group metals (PGMs), titanium and vanadium from surface, reinforcing its potential for a significant sulphide deposit in the low-risk West Musgrave region. Highlights from phase one diamond drilling include, 7.7 metres at 0.27% copper, 18.4% titanium and 0.68% vanadium. Phase two RC drilling highlights include 5 metres at 0.86 g/t PGE, 0.26% copper and 19.2% titanium. Pending assays from 68 additional drill holes are expected to expand the resource. The first round of infill drilling at Reef 1 has reinforced the company’s confidence in the discovery’s continuity and scale. The project is geologically analogous to South Africa's Bushveld Complex, a globally significant source of critical minerals. Terra Metals plans to continue systematic exploration while advancing metallurgical test work, with updates expected in 2025. The company remains committed to proving the full potential of the Dante Reefs discovery. #ProactiveInvestors #TerraMetals #ASX #OTC #DanteReefs, #Copper, #PGMs, #Titanium, #Vanadium, #CriticalMinerals, #BushveldStyle, #MiningExploration, #WestMusgrave, #AustralianMining, #ResourceExpansion, #MineralDiscovery, #MetallurgicalTesting, #Tier1Mining, #MiningPotential, #GoldExploration, #MiningUpdates, #SustainableMining, #Mineralisation
…
continue reading
607 episoade
Toate episoadele
×Livium Ltd (ASX:LIT, OTC:LMMFF) managing director and CEO Simon Linge talks with Proactive’s Tylah Tully about the company’s latest updates, focusing on its strategic initiatives and near-term goals. Linge highlighted Livium’s strong emphasis on scaling its battery recycling business to meet the growing influx of large-format lithium-ion batteries, positioning the company as a key player in this growing sector. He discussed two other patented technologies, including LieNA® technology, developed in partnership with Mineral Resources, which is moving to its next phase of development. Additionally, Livium’s battery materials technology has made progress with customer agreements and product portfolio advancements, enabling the company to scale this segment. Linge explained how the organisation was actively pursuing funding opportunities through strategic, public and private partnerships. On restructuring, Linge outlined the ongoing cost-saving measures and workforce changes designed to position Livium for sustainable growth through 2026. He emphasised the company’s commitment to securing battery recycling agreements and a pipeline for large-format battery supplies, which are expected to reach 25,000 tonnes by the end of the decade. Stay tuned for further updates on Livium’s recycling milestones, restructuring developments, and commercialisation efforts. #ProactiveInvestors #LiviumLtd #ASX #OTC #BatteryRecycling #LithiumIonBatteries #EnergyStorage #SustainableTechnology #ASXLIT #BatteryMaterials #CircularEconomy #SimonLinge…
Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from Leeuwin Metals Ltd (ASX: LM1). Leeuwin Metals has raised A$3.25 million through a two-tranche share placement priced at A$0.098 per share, reflecting an 18.3% discount to the last closing price. The placement attracted strong interest from institutional and sophisticated investors, with contributions of approximately A$250,000 from directors and management, subject to shareholder approval. The placement comprises two tranches: Tranche 1 raised approximately A$1.55 million, while Tranche 2 is expected to raise A$1.7 million, contingent on shareholder approval at an extraordinary general meeting scheduled for February 2025. The funds will support exploration and drilling activities across Leeuwin’s Australian and Canadian project portfolio, working capital and placement costs. A key focus is the Marda Gold Project in Western Australia, which Leeuwin is acquiring from Ramelius Resources. Announced in December 2024, the acquisition is anticipated to conclude in Q1 2025. Leeuwin's management highlighted the strategic significance of the Marda acquisition, located in a renowned goldfield, as a growth opportunity for shareholders. The funding positions the company to advance its exploration programs across its highly prospective assets. #ProactiveInvestors #LeeuwinMetals #GoldMining #CapitalRaising #MardaGoldProject #ASXUpdate #InstitutionalInvestors #SophisticatedInvestors #GoldExploration #WesternAustralia #CanadaMining #MineralResources #SharePlacement #RameliusResources #MineralExploration #MiningProjects #CorporateUpdate #ExplorationFunding #InvestmentOpportunities #GoldFields #ASXNews…
1 Sona Nanotech's cancer treatment study published in peer-reviewed journal Frontiers in Immunology 6:25
Sona Nanotech CEO David Regan joined Steve Darling from Proactive to share the publication of groundbreaking findings from the company’s pre-clinical breast cancer and melanoma efficacy studies in the prestigious scientific journal Frontiers in Immunology. This comprehensive research highlights the transformative potential of Sona’s Targeted Hyperthermia Therapy (THT) and includes critical new follow-up data on its immune-activating properties. Sona’s proprietary technology employs patented, biocompatible gold nanorods (GNRs) to deliver precision, non-invasive hyperthermia therapy directly to cancer cells. This approach minimizes systemic toxicity, a common drawback of traditional cancer treatments. The study demonstrated that Sona’s THT induces cancer-specific cell death while triggering a robust immune response, marking a significant breakthrough in cancer immunotherapy. Notably, the research revealed that the immune response activated by Sona’s THT is effective against cancers that are typically resistant to modern immunotherapies. This novel immunity offers a critical advantage, paving the way for new treatment possibilities in cases where conventional methods fall short. #proactiveinvestors #sonananotechinc #cse #sona #otcqb #snanf #CancerResearch #GoldNanorods #TargetedTherapy #Biotechnology #CancerTreatment #HyperthermiaTherapy #Immunology #MedicalBreakthroughs #Nanotechnology…
AOTI Inc (AIM:AOTI) CEO, president, and co-founder Dr Mike Griffiths talked with Proactive about the company’s efforts to revolutionise chronic wound care. AOTI is focused on treating conditions like diabetic foot ulcers with its unique home-based oxygen therapy, designed to promote durable healing. Griffiths highlighted the staggering $80 billion US diabetic foot ulcer care market and shared that AOTI is well-positioned to expand within this space. He noted that AOTI’s strong clinical evidence and ability to reduce hospitalisations and amputations resonate strongly with payers and healthcare providers. He also shared recent milestones, including the company’s expansion into six Medicaid states, its five-year renewal of the Veterans Affairs contract, and ongoing efforts to broaden its international presence. Griffiths announced the start of enrolments for the venous leg ulcer (VLU) clinical trial and discussed its significance in building high-quality evidence for AOTI's therapy. AOTI, headquartered in the US and listed on AIM, has grown by over 30% annually for five years and Griffiths expects this growth to continue as it enters new markets like skilled nursing and long-term care. “We believe we’re in a very exciting sector, with solutions that deliver long-term outcomes,” he shared. Visit Proactive’s YouTube channel for more videos, and don’t forget to like, subscribe, and enable notifications for updates! #AOTI #ChronicWoundCare #DiabeticFootUlcers #MedicalTechnology #HealthcareInnovation #OxygenTherapy #Medicaid #VeteransAffairs #ClinicalTrials #MedTechGrowth…
hVIVO PLC CEO Yamin 'Mo' Khan talked with Proactive's Stephen Gunnion about the company's involvement in a world-first Phase 3 human challenge trial for a pertussis (whooping cough) vaccine candidate. The trial, in partnership with ILiAD Biotechnologies, is expected to start in the second half of this year. Khan highlighted the importance of this milestone for hVIVO, noting that it will be the company's largest challenge trial to date and its first bacterial challenge trial. The trial data aims to secure FDA marketing authorisation, marking a pivotal moment for the utility of human challenge trials in vaccine development. According to Khan, "The goal is to get a better vaccine to patients faster. Pertussis is a severe disease, particularly for infants, and there's an urgent need for new vaccines." He further explained that hVIVO's state-of-the-art Canary Wharf facility will play a critical role in supporting this trial, equipped with expanded laboratory capabilities for bacterial analysis. The trial comes as cases of pertussis are on the rise, increasing sixfold between 2023 and 2024. ILiAD Biotechnologies has also secured FDA fast-track status and an MHRA innovation passport for this vaccine candidate. Khan emphasised the partnership's goal of addressing this unmet medical need and delivering an effective vaccine to patients worldwide. Visit Proactive's YouTube channel for more videos, and don’t forget to like, subscribe, and enable notifications for future updates. #hVIVO #VaccineDevelopment #WhoopingCough #Pertussis #ClinicalTrials #FDAApproval #BiotechInnovation #Phase3Trial #HumanChallengeTrials #HealthcareResearch…
Fineqia International Inc CEO Bundeep Singh Rangar talked with Proactive's Stephen Gunnion about launching the world’s first exchange-traded product (ETP) that deploys digital assets in yield-bearing decentralized finance (DeFi). Rangar explained the product's unique value, providing access to DeFi yield through a transparent, regulated security listed on the Vienna Stock Exchange. The Fineqia FTSE Cardano Enhanced Yield ETN (AV:YADA) is based on the Cardano network, a top ten cryptocurrency valued at over $35 billion, and allows investors to participate in DeFi activities such as borrowing, lending, and validating transactions, which generate fees. Unlike traditional ETFs and ETNs, Fineqia's product reinvests 80% of these yields back to investors, making it a truly innovative approach. Rangar highlighted the importance of partnering with FTSE Russell, a subsidiary of the London Stock Exchange, to ensure robust pricing data for this groundbreaking product. He added, "This is an icebreaker for what we want to do in the industry... We’re about being innovative and different." This collaboration sets a milestone for the ETP industry by combining blockchain technology and traditional finance, giving fund managers and retail investors easy access to decentralized finance through a familiar financial instrument. Visit Proactive's YouTube channel for more videos like this one, and don’t forget to give the video a like, subscribe to the channel, and enable notifications for updates! #Fineqia #DeFi #CryptoETP #DecentralizedFinance #Cardano #DigitalAssets #ETN #CryptoInvesting #Blockchain #FTSERussell…
GoviEx Uranium Inc (TSX-V:GXU, OTCQX:GVXXF) CEO Daniel Major discussed the just-released feasibility study for the Mutanga Uranium project in Zambia with Proactive's Stephen Gunnion. Major highlighted that the study outlines solid project economics, including a net present value (NPV) of $243.00 million and an internal rate of return (IRR) of 20.8% at a uranium price of $90.00 per pound. He described Mutanga as a straightforward open-pit project benefiting from local infrastructure and low technical risks. The company plans to produce 2.20 million pounds of uranium annually over a 12-year lifespan. Major emphasised the potential for resource expansion from nearby satellite deposits, which could further enhance the project’s value. Additionally, he outlined the global uranium market dynamics, noting a deficit in supply and growing demand driven by new reactors, life extensions for existing reactors, and advancements in small modular reactors (SMRs). Looking ahead, GoviEx is targeting project construction by 2028 and is actively seeking debt financing and offtake agreements to move forward. Major said, "We’re already sharing our feasibility study with utilities to ensure we meet their requirements." Watch the full interview to learn more about GoviEx’s strategy for meeting global uranium demand. Don’t forget to like the video, subscribe to Proactive’s YouTube channel, and enable notifications for future updates! #GoviExUranium #MutangaProject #UraniumMining #ZambiaResources #EnergyDemand #UraniumFeasibility #LowRiskMining #GlobalEnergy #NuclearEnergy #SmallModularReactors…
1 ANGLE PLC says Nature Medicine journal highlights Parsortix's role in cancer breakthrough 11:25
11:25
Redare mai Târziu
Redare mai Târziu
Liste
Like
Plăcut
11:25ANGLE PLC (AIM:AGL, OTCQX:ANPCY) CEO Andrew Newland talked with Proactive's Stephen Gunnion about groundbreaking research using the Parsortix system. This system has enabled significant advancements in cancer research, including a recent study published in Nature Medicine that explores stopping the metastatic spread of cancer. Newland explained how Parsortix helps identify and analyse circulating tumour cell clusters, which are critical to cancer progression. He highlighted research led by Professor Nicola Aceto at the Cancer Metastasis Laboratory in Zurich, where they discovered that FDA-approved cardiac drugs could break these clusters into individual cells. In mice and breast cancer patients, this approach showed potential to halt cancer progression. The CEO emphasised Parsortix's central role in identifying patients and monitoring treatment efficacy, predicting global interest and demand for the system. He also discussed ANGLE's broader work with cancer drug developers, including collaborations with companies like AstraZeneca and Eisai, to unlock new approaches to managing cancer. Newland concluded with optimism, envisioning a future where cancer could become a manageable condition, similar to how HIV/AIDS is now controlled. Discover more about this transformative research and ANGLE PLC’s contributions. Like this video, subscribe to Proactive’s channel, and enable notifications for future updates!" #ANGLEPLC #Parsortix #CancerResearch #CancerBreakthrough #Oncology #Metastasis #CirculatingTumorCells #MedicalInnovation #NatureMedicine #CancerAwareness…
Iofina PLC (AIM:IOF, OTC:IOFNF) CEO Dr Tom Becker talked with Proactive's Stephen Gunnion about the company's record achievements in 2024 and its ambitious growth plans for 2025. Becker detailed the production of over 630 metric tons of iodine last year, including a 13% year-over-year increase. He highlighted that the new IO#10 plant, which reached full capacity in late 2024, will contribute significantly to this year's output. The company is also making strides with IO#11, set to begin production in Q3 2025, and ongoing discussions for IO#12, signalling further expansion. Becker emphasised strong global iodine demand, with prices climbing above $70 per kilogram, benefiting Iofina's operations. Despite minor shipping delays pushing sales into 2025, Becker assured investors of continued growth and progress. He also celebrated the company's safety track record, with no lost-time accidents since 2021. Stay tuned for more updates on Iofina PLC and its plans for the future. Don’t forget to like the video, subscribe to Proactive’s YouTube channel, and enable notifications for future updates!" #Iofina #IodineProduction #ChemicalIndustry #BusinessGrowth #RecordProduction #IO10Plant #IO11Plant #GlobalDemand #ChemicalSafety #ProactiveInvestors…
Lisata Therapeutics Inc (NASDAQ:LSTA) CEO David Mazzo joined Proactive's Stephen Gunnion with an update on the company's pancreatic cancer trials. The company recently announced preliminary results from its ASCEND phase 2 trial at the ASCO Gastrointestinal Conference. According to Mazzo, data from the randomized, double-blind, placebo-controlled Cohort A group demonstrated promising trends in overall survival and efficacy. He highlighted that four complete responses were observed in the Certepetide group out of 63 patients—a stark contrast to zero in the standard care group. This is particularly significant when compared to other trials, such as NAPOLI-3, which had only one complete response in nearly 400 patients. Mazzo also discussed Cohort B, which investigates a double-dose regimen of Certepetide to explore pharmacodynamic improvements and optimize treatment efficacy. In addition, Lisata released preliminary data from its iLSTA trial, which examines combining Certepetide with immunotherapy (Durvalumab) and cytotoxics for pancreatic cancer. Mazzo emphasized increased T-cell tumor penetration and higher partial response rates in early data, suggesting potential for enhanced treatment outcomes. Catch the full interview to learn more about these breakthroughs. Visit Proactive’s YouTube channel for updates, like this video, subscribe, and enable notifications to stay informed. #LisataTherapeutics #PancreaticCancer #ClinicalTrials #ASCENDTrial #Certepetide #CancerResearch #Immunotherapy #PharmaNews #BiotechInnovations #ProactiveInvestors…
1 ImmuPharma CEO Tim McCarthy shares latest developments with P140 platform, road ahead 12:35
12:35
Redare mai Târziu
Redare mai Târziu
Liste
Like
Plăcut
12:35ImmuPharma PLC (AIM:IMM) CEO Tim McCarthy joined Stephen Gunnion in the Proactive studio to discuss the company’s recent groundbreaking developments in autoimmune disease treatment. He highlighted the progress made with their P140 platform, emphasising its potential to address multiple autoimmune diseases and transform patient care. McCarthy explained, “This is a breakthrough in a lot of different ways,” referencing recent preclinical findings that allow the identification and categorisation of autoimmune diseases, paving the way for personalised medicine. He also noted the significant interest in P140 from major pharmaceutical companies, underlining its potential to deliver effective treatment without adverse effects. Additionally, McCarthy shared updates from the JP Morgan and Biotech Showcase conferences, where these advancements were presented to key industry players. ImmuPharma’s focus in 2025 includes expanding its partnerships and delivering on its transformative pipeline. Stay tuned for more updates on ImmuPharma’s innovations in the biotech space. Visit Proactive’s YouTube channel for more videos, and don’t forget to like, subscribe, and turn on notifications for future content. #ImmuPharma #AutoimmuneDiseases #P140Platform #PersonalizedMedicine #Biotech #TimMcCarthy #PharmaceuticalInnovation #LupusTreatment #CIDP #HealthcareRevolution…
1 Giyani Metals announces 'transformative' SEZ licence in Botwana for commerical managanese plant 4:24
Giyani Metals Corp (TSX-V:EMM, OTC:CATPF) CEO Charles FitzRoy joined Proactive's Stephen Gunnion with news that the company has secured a 50-year Special Economic Zone (SEZ) Investor License for its battery-grade manganese (HPMSM) commercial plant site to be built in Botswana. The award of the SEZ License designates Giyani’s Commercial Plant as a Single Factory Special Economic Zone. The Commercial Plant will be located adjacent to its K.Hill manganese mine site, near Kanye, Botswana. FitzRoy said securing the SEZ License for its Commercial Plant is a transformative step for Giyani, and an important milestone on its path to becoming a leading producer of battery-grade manganese, particularly as its Demo Plant nears first production.…
HeLIX Exploration PLC (AIM:HEX) chairman David Minchin joined Proactive's Stephen Gunnion with news that the company has upgraded its helium reserves and economic estimates for the Rudyard Project, in Montanta, and raised around £5 million through an equity issuance. The proceeds are earmarked to support spending on a gas processing plant and to progress the Rudyard and Ingomar Dome projects. Minchin said the decision to move forward with an equity raise comes after a detailed review of the economic model and terms of available debt finance. Helix announced that consultant Aeon Petroleum Consultants Corp has calculated helium reserves of 355 million cubic feet in the northern dome of the Rudyard Project. Over a 12.5-year project lifespan, Aeon estimates potential net revenue of $115.2 million and sets an asset valuation an NPV8 valuation of $77.9 million, assuming a helium price of $500 per thousand cubic feet (Mcf).…
Ariana Resources PLC (AIM:AAU) managing director Kerim Sener talked with Proactive's Stephen Gunnion about the company’s production results and ongoing projects. Ariana has exceeded production guidance for the eighth consecutive year at its Zenit mining operation in Turkey, delivering nearly 21,000 ounces of gold in 2024. Sener emphasised that the Kiziltepe processing plant continues to perform well despite its age, aided by additional ore from the Tavsan operation. The company reported gross revenue of $54.70 million, its second-highest ever, bolstered by strong gold and silver prices. Sener noted favourable market conditions, supported by central bank buying and commodity price trends, which he expects to continue into 2025. Sener also highlighted exploration progress in Zimbabwe, with new assay results being integrated into a forthcoming resource model for the Dokwe project. Meanwhile, drilling in Kosovo's Slivova gold project is helping Ariana complete its earn-in to 51% of the project, with further updates expected soon. Sener expressed optimism for 2025, stating, "At the moment, we're hitting all our guidance figures and continuing to do well across exploration and development." For more updates on Ariana Resources, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe to our channel, and enable notifications for the latest news. #ArianaResources #GoldMining #TurkeyMining #ZimbabweExploration #KosovoGold #GoldPrices #GoldRevenue #MiningUpdate #InvestorNews #ProactiveInterviews…
Greatland Gold PLC (AIM:GGP, OTC:GRLGF) CEO Shaun Day talked with Proactive's Stephen Gunnion about the company's strong production numbers for December following the completion of the Telfer and Havieron acquisition, consolidating ownership under Greatland. The company delivered 33,000 ounces of gold equivalent in just 27 days. Day emphasised the robust financial position of Greatland, with $145 million in cash and an undrawn debt facility of $75 million, providing over $220 million in liquidity to support its mine plans and life extensions at Telfer. "One of the positive variances to that due diligence is just the receptiveness and the culture at site to being part of Greatland," said Day. He outlined key upcoming milestones, including the release of the Telfer JORC resource in Q1, the ASX cross-listing in Q2, and the Havieron feasibility study expected in the second half of the year. With plans for ongoing updates, shareholders can look forward to consistent progress throughout the year. Visit Proactive’s YouTube channel for more videos. Don’t forget to give this video a like, subscribe to the channel, and enable notifications for future updates. #GreatlandGold #MiningIndustry #GoldProduction #TelferMine #HavieronProject #ASXListing #MiningNews #GoldInvesting #ShaunDay #ResourceDevelopment…
P
Proactive - Interviews for investors
The global oncology drug market, valued at USD 231.56 billion in 2024, is expected to grow to USD 532.91 billion by 2031, driven by demand for targeted therapies, biomarker-based treatments, and immunotherapies. Several ASX-listed companies are contributing to this innovation: Arovella Therapeutics Ltd: Developing its invariant Natural Killer T (iNKT) cell therapy platform to treat blood cancers and solid tumours. Lead product ALA-101 uses CAR19-iNKT cells to target the CD19 antigen. The company recently raised $20 million to fund a phase 1 trial for CD19-positive blood cancers. Race Oncology Ltd: Focused on its lead asset, bisantrene, a small-molecule chemotherapeutic with reduced cardiotoxicity. A reformulated version, RC220, is being developed to meet unmet oncology needs. Imugene Ltd: Advancing immuno-oncology therapies, including azer-cel, an off-the-shelf CAR T therapy targeting CD19 for blood cancers, B-cell vaccine candidates, and CF33 oncolytic virotherapy, which combines engineered viruses with immunotherapies for solid tumours. Prescient Therapeutics Ltd: Developing personalised cancer treatments with technologies from institutions like Yale and Oxford. Lead drug PTX-100 has FDA Orphan Drug Designation for T-cell lymphomas. Its OmniCAR and CellPryme platforms enhance CAR-T therapies for improved efficacy and adaptability. These companies exemplify the growth and innovation occurring within the oncology sector. #ProactiveInvestors #ASX #OncologyMarket #ASXCompanies #ArovellaTherapeutics #RaceOncology #Imugene #PrescientTherapeutics #CancerResearch #ImmunoOncology #CellTherapy #TargetedTherapies #CAR_T #PersonalisedMedicine #CancerCare #BiotechNews #OncologyInnovation #GlobalHealthcare #ClinicalTrials #FDAApproval #SolidTumours #BloodCancers…
P
Proactive - Interviews for investors
Proactive’s Tylah Tully breaks down ‘Just the facts’ of the latest news from Silver Mines Ltd (ASX:SVL). The company has announced the commencement of drilling at its Elsienora Project, part of the Tuena Gold Project in New South Wales. Located 80 kilometres south of Orange, the project includes multiple gold and silver prospects. Historical exploration highlights include: 29 metres @ 1.53 g/t gold from surface, 8 metres @ 3.14 g/t gold from 30 metres, and 21 metres @ 0.89 g/t gold from 207 metres. Gold mining in the area dates back to the 1860s, with historical production records showing 6,758 ounces of gold from Washington Mine and 2,633 ounces from Victoria Mine. The initial program includes 2,000–3,000 metres of diamond drilling targeting gold and silver, as well as induced polarisation (IP) surveys and reprocessing of historical data. The company will also investigate historical workings and underexplored targets within adjoining licence EL8974. Drilling is expected to begin this quarter, pending statutory approvals. #ProactiveInvestors #SilverMines #ASX #ElsienoraProject #TuenaGoldProject #GoldExploration #SilverExploration #DiamondDrilling #MineralExploration #NSWMining #HistoricMining #ResourceDevelopment #MiningUpdates #ASXStocks #IPSurveys #GeologicalExploration #GoldTargets #SilverTargets #MineralProspects #ExplorationDrilling #MiningNews #JustTheFacts…
P
Proactive - Interviews for investors
Proactive’s Tylah Tully breaks down ‘Just the facts’ of the latest news from Maximus Resources Ltd (ASX:MXR, OTC:MXRRF). Maximus has identified shallow high-grade gold mineralisation at the Eagles Nest deposit, 7 kilometres south of the Wattle Dam Gold Project in Western Australia’s Eastern Goldfields. Recent reverse circulation (RC) drilling produced significant results, including: 10 metres @ 2.24 g/t gold from 37 metres, including 2 metres @ 2.71 g/t and 3 metres @ 3.88 g/t. Additional scout drilling along the Eagle’s Nest–Groundlark corridor revealed promising anomalies, such as 1 metre @ 1.12 g/t gold and 8 metres @ 0.76 g/t gold. The drilling program comprised 11 RC holes to validate historical data and assess shallow mineralisation, while scout drilling targeted untested zones within a 3-kilometre corridor. Eagles Nest hosts an existing resource of 42,550 ounces at 2.0 g/t gold and remains open at depth and along strike. The shallow, free-milling nature of the mineralisation supports its potential as a low-cost and expedited development opportunity. Further exploration, including additional drilling and resource modelling, is planned to evaluate the scale and economic potential of the deposit. #ProactiveInvestors #MaximusResources #ASX #OTC #EaglesNest #GoldExploration #WattleDam #EasternGoldfields #GoldMining #DrillingResults #MineralExploration #ASXStocks #GoldDeposits #WesternAustralia #ExplorationUpdates #MiningNews #ResourceExpansion #HighGradeGold #GoldProspects #SystematicDrilling #LowCostDevelopment #MiningOpportunities #GoldCorridor…
P
Proactive - Interviews for investors
Proactive’s Tylah Tully breaks down ‘Just the facts’ of the latest news from Altech Batteries Ltd (ASX:ATC, OTC:ALTHF). Altech announced that its CERENERGY® Sodium Chloride Solid State Battery project has achieved the highest “Dark Green” rating from Standard and Poor’s Global Ratings. This rating underscores the project’s status as one of the most environmentally sustainable battery technologies, with low carbon emissions, minimal supply chain requirements, and reduced environmental impact. The CERENERGY® battery produces one-third of the emissions of lithium-ion batteries, with total emissions estimated at 14 kgCO₂/kWh compared to 61–106 kgCO₂/kWh for lithium-ion alternatives. It is powered entirely by renewable energy and relies on abundant, recyclable materials such as sodium and alumina, avoiding critical minerals like lithium, cobalt and copper. The project aligns with ICMA Green Bond Criteria, enabling access to the USD 250 billion green bond market, a significant portion of which operates in Europe. While the green shading score does not affect bond pricing, it offers transparency for investors regarding climate risks and impacts. Altech is proud of this milestone and foresees strong demand for the CERENERGY® battery in applications such as industrial microgrids, grid storage and heavy industries. #ProactiveInvestors #AltechBatteries #ASX #OTC #CERENERGY #DarkGreenRating #GreenBonds #SustainableEnergy #BatteryStorage #RenewableEnergy #EcoFriendly #LowEmissions #EnergyTransition #SCSSBattery #RecyclableMaterials #Innovation #ClimateAction #CleanEnergy #SodiumBatteries #BatteryTechnology #CarbonReduction #GreenInvestment #GridStorage…
P
Proactive - Interviews for investors
Tolu Minerals Ltd (ASX:TOK) CEO Iain Macpherson talks with Proactive’s Tylah Tully about the company’s progress and strategic initiatives at the Tolukuma Gold Mine in Papua New Guinea. Macpherson discussed the commissioning of a new modular gravity circuit plant designed to streamline production and reduce operational costs. He also highlighted improvements to road infrastructure, including rerouting efforts to ensure stability and better access to the mine. A notable update was the appointment of Chris Muller as executive group geologist. Macpherson emphasised Muller’s extensive experience in gold resource growth, which will enhance the company’s exploration strategies. Muller’s track record includes discoveries of multi-million-ounce gold deposits and his addition underscores Tolu Minerals’ focus on accelerating resource growth. Macpherson also shared updates on the company’s hydroelectric power station plans and exploration priorities. Leveraging data from recent airborne surveys, Tolu Minerals aims to expand its current resource estimate of 2-3 million ounces while optimising shareholder value. Production is set to begin imminently, marking 2025 as a pivotal year for the company. #ProactiveInvestors #ToluMinerals #ASX #TolukumaGoldMine #GoldExploration #ChrisMuller #HydropowerProjects #MiningUpdates #GoldMining #PapuaNewGuineaMining #InvestingInMining…
Cyprium Metals Ltd (ASX:CYM, OTC:CYPMF) executive chair Matt Fifield talks with Proactive’s Tylah Tully about the company's latest developments and its ambitious 2025 plans. Fifield emphasised the transformational impact of 2024, which included the release of a pre-feasibility study (PFS) for the Nifty Copper Complex in Western Australia. This study detailed plans for surface mining and a refurbished concentrator, projecting a net present value of $1 billion, $4 billion in life-of-mine cash flow and 20 years of reserves. Fifield also announced a significant strategic alliance with Macmahon Holdings Ltd, calling it "massive" for Cyprium Metals. He explained that Macmahon’s expertise, presence in Western Australia and familiarity with large-scale operations made them an ideal partner to execute the bankable feasibility study and support project implementation. "This partnership ensures the best pathway forward with a tier-one contractor," he said. To finance the project, Cyprium Metals is exploring multiple avenues, including leveraging its Glencore offtake facility, engaging government-backed lender, and considering strategic investors for a minority stake in Nifty. These initiatives are part of the company’s clear plans to deliver value in 2025. #ProactiveInvestors #CypriumMetals #ASX #OTC #NiftyCopperComplex #Macmahon #CopperMining #MiningNews #MattFifield…
P
Proactive - Interviews for investors
Proactive’s Tylah Tully breaks down ‘Just the facts’ of the latest news from Brightstar Resources Ltd (ASX:BTR). Brightstar has announced final results from its 6,000-metre reverse circulation (RC) drilling program at the Sandstone Gold Project in Western Australia’s Murchison region. The program targeted the Montague-Boulder and Whistler deposits, with key intercepts including 4 metres at 59 g/t gold at Whistler and 2 metres at 33.7 g/t gold at Montague-Boulder. The Whistler program, totalling ~3,300 metres, focused on infill drilling below the existing open pit to improve resource classification and included extensional drilling to test mineralisation at its northern and southern extents. Significant results include 5 metres at 7.64 g/t gold and 9 metres at 7.16 g/t gold. The Montague-Boulder program (~2,800 metres) explored extensions of the deposit, uncovering high-grade mineralised shoots, including 1 metre at 66.7 g/t gold and 7 metres at 5.39 g/t gold. Brightstar has also commenced its 2025 drilling campaign at the Lord Nelson and Vanguard North deposits, aiming to expand the Sandstone Gold Project’s 1.5-million-ounce mineral resource base. Drilling has resumed at the Lord Nelson deposit, with additional results expected as pending assays from the 2024 drill season are finalised. The company continues exploration alongside development of the Fish underground mine at the Laverton Hub. #ProactiveInvestors #BrightstarResources, #GoldMining, #SandstoneProject, #GoldExploration, #RCDrilling, #HighGradeGold, #AustraliaMining, #WesternAustralia, #MontagueBoulder, #WhistlerDeposit, #LordNelson, #GoldProjects, #MineralResources, #MiningUpdates, #GoldAssays, #ExplorationDrilling, #GoldInvesting, #FeasibilityStudy, #MiningIndustry, #Brightstar…
P
Proactive - Interviews for investors
Proactive’s Tylah Tully breaks down ‘Just the facts’ of the latest news from Nova Minerals Ltd (ASX:NVA, NASDAQ:NVA). Nova has identified significant high-grade potential at its Estelle Gold and Critical Minerals Project in Alaska’s Tintina Gold Belt. Recent surface sampling at the Wombat prospect delivered exceptionally high-grade results, including 360 g/t gold—the second-highest gold sample recorded at Estelle—and gallium concentrations up to 74.5 ppm. Gallium, listed as a critical mineral by the USGS, is in demand by the US Department of Defense following China’s export restrictions. During the 2024 exploration program, 511 soil samples, 225 rock samples, and 5 tonnes of bulk material were collected. Key highlights include: Wombat: Seventeen rock samples, seven exceeding 2 g/t gold, with grades of 360 g/t and 93.2 g/t gold. Stoney: Samples returned 6.1 g/t gold, 124 ppm silver, 2.4% copper, and 340 ppm antimony. Muddy Creek: Extended high-grade gold mineralisation by 400 metres, with samples up to 128.5 g/t gold. Stibium: An 800-metre by 400-metre zone yielded antimony grades up to 56.7% and gold up to 141 g/t. These results reinforce Estelle’s status as a dual-purpose gold and critical minerals project. Planned drill testing will further evaluate the potential of this promising claim block. #ProactiveInvestors #NovaMinerals, #ASX #NASDAQ #EstelleProject, #GoldExploration, #CriticalMinerals, #Gallium, #GoldMining, #TintinaGoldBelt, #AlaskaMining, #Stibium, #MuddyCreek, #WombatProspect, #MineralExploration, #USDefense, #HighGradeGold, #RareEarthElements, #SustainableMining, #ExplorationUpdates, #MiningIndustry, #ResourceExpansion, #ProactiveAustralia…
P
Proactive - Interviews for investors
Proactive’s Tylah Tully breaks down ‘Just the facts’ of the latest news from Tamboran Resources Corporation (ASX:TBN, NYSE: TBN). Tamboran has signed a non-binding MoU with Santos Ltd to collaborate on technical studies for the potential expansion of the Darwin LNG (DLNG) facility in Australia’s Northern Territory. The expansion, referred to as Train 2, could increase the facility’s LNG capacity by ~6 million tonnes per annum (MTPA), adding to the existing 10 MTPA operation at Middle Arm. The MoU also focuses on commercialising natural gas from the jointly owned EP 161 acreage in the Beetaloo Basin, where Santos holds a 75% stake and Tamboran owns 25%. Tamboran estimates the Beetaloo Basin holds approximately two million net prospective acres, with significant gas resources capable of supplying Northern Territory and East Coast gas markets for decades. Tamboran is advancing its Northern Territory LNG (NTLNG) project, currently in pre-FEED studies, while aiming to supply gas to domestic and international LNG markets, including Darwin and Gladstone. The long-standing partnership between Tamboran and Santos in the Beetaloo Basin underscores the potential for unlocking further shale gas resources to support LNG expansion efforts. Tamboran’s strategic efforts are designed to deliver value for shareholders and contribute to Australia’s energy market. #ProactiveInvestors #TamboranResources, #ASX #NYSE #SantosLtd, #DarwinLNG, #BeetalooBasin, #NaturalGas, #ShaleGas, #LNGMarkets, #EnergyExpansion, #EP161, #DLNGTrain2, #NorthernTerritory, #PreFEED, #GasCommercialisation, #LNGCapacity, #EnergyPartnership, #AustraliaGasMarket, #ASXEnergy, #TamboranSantos, #ShareholderValue, #ProactiveAustralia…
P
Proactive - Interviews for investors
Proactive’s Tylah Tully unpacks the outlook for key commodities, focusing on battery metals and related critical minerals. Despite challenges in 2024, demand for materials like lithium, cobalt, copper, graphite, vanadium and nickel remains strong due to ongoing global decarbonisation and transport electrification. While lithium and nickel saw price corrections and slower EV sales impacted mining activities, long-term projections indicate sustained demand for these essential metals. Sovereign Metals Ltd continues advancing the Kasiya Project in Malawi, which holds the world’s largest known natural rutile deposit and the second-largest flake graphite deposit. Kasiya integrates sustainable mining with conservation farming through its Pilot Mining and Land Rehabilitation Program. Sovereign aims to address the global demand for rutile and graphite while fostering community partnerships. Surefire Resources NL is developing the Victory Bore Iron-Vanadium-Titanium Project in Western Australia. Recent beneficiation of 700 kilograms of ore produced high-grade magnetite concentrate, which will undergo evaluation for downstream processing into vanadium pentoxide, ferrovanadium and other products. The project marks a milestone in Surefire’s commercialisation efforts. Latrobe Magnesium Ltd is tackling magnesium supply chain gaps with its $57 million demonstration plant. Using fly ash waste, LMG’s patented technology reduces CO₂ emissions by 60% and converts 100% of waste into saleable products. With global magnesium demand rising, LMG offers a sustainable alternative to China’s supply dominance. #ProactiveInvestors #SovereignMetals, #SurefireResources, #LatrobeMagnesium, #ASX, #RareEarthElements, #CriticalMinerals, #KasiyaProject, #VictoryBore, #Magnetite, #Rutile, #Graphite, #MagnesiumProduction, #SustainableMining, #Decarbonisation, #EnergyStorage, #EVBatteryMetals, #GreenTechnologies, #CircularEconomy, #MineralExploration, #MiningUpdates, #ProactiveAustralia…
Mosman Oil and Gas Ltd (AIM:MSMN) CEO Andy Carroll talked with Proactive’s Tylah Tully about the company’s latest acquisitions and strategic plans for 2025. Carroll shared insights on two newly acquired projects: Sagebrush and Coyote Wash. Sagebrush is an established oil production area, offering strong revenue potential and valuable infrastructure. Adjacent to it, the Coyote Wash Project features 3D seismic data and promising drill-ready helium and oil prospects. Carroll noted, “The Sagebrush project has been in production... giving us a very solid cornerstone of our helium exploration portfolio.” He also discussed the company’s capital allocation strategy, which focuses on U.S. projects for their shorter timelines and more accessible infrastructure compared to Australia. Additionally, Carroll provided an update on the Vecta Helium Project in Colorado, where progress has been delayed but remains a priority. Looking ahead, Mosman is finalising plans for drilling at Sagebrush and Coyote Wash, with activity expected to begin later this year. Carroll emphasised, “We look forward to drilling... hopefully by the end of this year.” #ProactiveInvestors #MosmanOilAndGas #AIMMSMN #HeliumExploration #OilAndGas #EnergyInvestments #SagebrushProject #CoyoteWash #EnergyNews…
P
Proactive - Interviews for investors
Orthocell Ltd (ASX:OCC, OTC:ORHHF) CEO Paul Anderson talked with Proactive’s Tylah Tully about the company’s key achievements in 2024 and its ambitious plans for 2025. Anderson highlighted the success of Remplir, their innovative nerve repair product, which launched in Australia to strong distributor uptake and achieved reimbursement. This success drove record revenues for three consecutive quarters and bolstered Orthocell’s share price and market capitalisation. Anderson explained how Remplir revolutionises nerve repair by minimising sutures, reducing surgical damage, and improving patient recovery times. Orthocell is advancing global expansion plans, with regulatory submissions in the US, Canada, Thailand, Europe, and Brazil. “This product is addressing a strong unmet clinical need,” Anderson stated, emphasising the company’s goal of capturing a 20% share of the $3.2 billion global nerve repair market. In 2025, Orthocell aims to strengthen its US infrastructure, collaborate with leading surgeons, and scale Remplir’s commercialisation worldwide. #ProactiveInvestors #Orthocell #Remplir #NerveRepair #ASXOCC #HealthcareInnovation #MedicalDevices #FDAApproval #GlobalExpansion #ProactiveStudio #2025Growth…
P
Proactive - Interviews for investors
1 Southern Cross Gold begins trading on the ASX, highlights Sunday Creek Gold and Antimony project 6:42
Southern Cross Gold CEO Michael Hudson joined Steve Darling from Proactive to share exciting updates with Proactive, marking the company's commencement of trading on the Australian Stock Exchange (ASX) under the ticker symbol “SX2.” The company, formed through the merger of Mawson Gold Limited and Southern Cross Gold, has taken strategic steps to consolidate its position as a significant player in the mining sector. A major highlight is the consolidation of ownership of the Sunday Creek gold project in Victoria, Australia, regarded as one of the world’s top gold and antimony discoveries. Hudson emphasized the extensive exploration efforts, including 70–80 kilometers of drilling, and the project's remarkable hit rates, which stand out within the mining industry. Southern Cross Gold aims to identify 3 million ounces of gold at ten grams per tonne through further exploration. The Victorian government has expressed strong support for the project, recognizing its potential to boost the local economy and global resources supply. Hudson also underscored the strategic importance of antimony, a critical metal with industrial and military applications, noting that most global supply is dominated by China and Russia. With Sunday Creek ranking among the top three non-Chinese and non-Russian antimony projects worldwide, it holds significant geopolitical and market value. #proactiveinvestors #asx #sx2 #tsxv #sxgc #GoldMining #SundayCreek #Antimony #MichaelHudson #MiningExploration #DualListing #CriticalMetals #GoldDiscovery #ProactiveInvestors…
P
Proactive - Interviews for investors
VettaFi Head of Thematic Strategy Jane Edmondson joined Steve Darling from Proactive about the ripple effects of President Trump’s proposed NATO defense spending increase and the evolving landscape of European defense investments. Trump's call to raise NATO member nations' defense spending from 2% to 5% of GDP has sparked varied responses. Countries like Poland have welcomed the initiative, while others, including Germany, have raised concerns over the financial burden. Edmondson noted that this proposal underscores a broader trend of increased military investment across Europe, driven by geopolitical tensions, particularly the ongoing Russia-Ukraine conflict. Edmondson highlighted the sharp rise in European defense stocks, with companies such as Rheinmetall, Saab, and Leonardo experiencing dramatic gains of 200% to 300% since the start of the conflict. This surge reflects the market's recognition of the urgent need for modernized defense capabilities after years of underfunding. She pointed to emerging initiatives like the development of a European defense industrial base and a potential defense bank to sustain military investments. Additionally, Trump's recent executive order reforming U.S. defense budgets further emphasizes a shift towards innovative technologies, such as artificial intelligence and robotics, over traditional defense programs. Edmondson predicted that a peaceful resolution to the Russia-Ukraine war could trigger short-term profit-taking in defense stocks. However, she emphasized that the long-term demand for defense investment remains strong, driven by NATO's evolving requirements and Europe's push for self-sufficiency in defense. #proactiveinvestors #vettafi #hanetf #DefenseSpending #Cybersecurity #NATO #DefenseETF #JaneEdmondson #VettaFi #DefenseTech #GlobalSecurity #Investing #MilitaryTech #trump…
P
Proactive - Interviews for investors
Protalix BioTherapeutics CEO Dror Bashan recently detailed the company’s vision for 2025, highlighting advancements in its proprietary ProCellEx platform and its commitment to addressing unmet medical needs. Protalix specializes in producing complex human proteins using plant cell technology, focusing on therapies for Fabry and Gaucher diseases while exploring new opportunities in other therapeutic areas. A key achievement in 2024 was the successful completion of a Phase 1 clinical trial for the company’s treatment candidate for gout. Positive trial results have set the stage for a Phase 2 study, scheduled to begin in mid-2025. Bashan also emphasized Protalix’s robust financial position, with the company becoming debt-free as of September 2024—a milestone that supports ongoing operations, clinical trials, and pipeline expansion. Protalix is also actively working to extend the reach of Elfabrio, its FDA-approved therapy for Fabry disease. Additionally, the company is leveraging its innovative platform to explore next-generation solutions in renal and other therapeutic areas, aiming to broaden its impact on patient care. Looking ahead, Protalix plans to focus on addressing unmet needs in renal therapies while continuing to build on the success of its current treatments. With a strong financial foundation and a dedication to innovation, the company is well-positioned for transformative growth in 2025 and beyond.…
Bun venit la Player FM!
Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.